Comparison of triglyceride-glucose index and HOMA-IR in assessing insulin resistance in acromegaly: a case-control study
Endokrynologia Polska · 2025
DOI: 10.5603/ep.105752 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endokrynologia Polska, 2025. Verfasst von Yusuf Karadeniz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Metabolism, Karaman Training and Research Hospital, Karaman, Türkiye. dryusufkaradeniz…. Hauptthemen laut MEDLINE: Insulin Resistance, Acromegaly, Blood Glucose, Triglycerides. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
The objective was to assess the triglyceride-glucose (TyG) index and the homeostatic model assessment for insulin resistance (HOMA-IR) in the evaluation of insulin resistance in patients with acromegaly and to compare results with healthy controls. Material and methods: A retrospective case-control study was conducted at the Department of Endocrinology, Necmettin Erbakan University, Meram Faculty of Medicine. The study included 50 acromegalic patients and 50 age- and sex-matched healthy controls.
Results
The median age and sex distribution were similar between the acromegaly and control groups (p > 0.05). Compared to the control group, acromegalic patients had significantly higher fasting glucose, HbA1c, total cholesterol, triglyceride, TyG index, and AST levels (p < 0.05 for all), while hemoglobin and platelet counts were significantly lower (p < 0.05). Diabetes mellitus (DM) was present in 24.0% of acromegalic patients. Compared to those without DM, acromegalic patients with DM were significantly older, had greater frequency of cardiovascular disease, and higher glucose, HbA1c, and neutrophil levels (p < 0.05). The TyG index showed a significant correlation with fasting glucose in both groups, but it correlated with insulin and HOMA-IR only in controls.
Conclusion
Acromegalic patients exhibit significant metabolic alterations, including higher TyG index levels and increased DM prevalence, despite having similar HOMA-IR values to healthy controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Karaman Training and Research Hospital, Karaman, Türkiye. dryusufkaradeniz@gmail.com.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Konya City Hospital, Konya, Türkiye.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Sakarya Training and Research Hospital, Sakarya, Türkiye.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Tokat State Hospital, Tokat, Türkiye.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye.
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Afyonkarahisar State Hospital, Afyonkarahisar, Türkiye.
ORCID-Profile: Yusuf Karadeniz, Hatice Caliskan Burgucu, Yusuf Ozturk, Zeliha Yarar, Hulya Kaynak, Mustafa Can, Melia Karakose
Zitieren
APA
Karadeniz, Y., Caliskan Burgucu, H., Ozturk, Y., Yarar, Z., Kaynak, H., Can, M., & Karakose, M. (2025). Comparison of triglyceride-glucose index and HOMA-IR in assessing insulin resistance in acromegaly: a case-control study. Endokrynologia Polska. https://doi.org/10.5603/ep.105752
Vancouver
Karadeniz Y, Caliskan Burgucu H, Ozturk Y, Yarar Z, Kaynak H, Can M, et al. Comparison of triglyceride-glucose index and HOMA-IR in assessing insulin resistance in acromegaly: a case-control study. Endokrynologia Polska. 2025. doi:10.5603/ep.105752
BibTeX
@article{Karadeniz2025,
author = {Karadeniz, Yusuf and Caliskan Burgucu, Hatice and Ozturk, Yusuf and Yarar, Zeliha and Kaynak, Hulya and Can, Mustafa and Karakose, Melia},
title = {Comparison of triglyceride-glucose index and HOMA-IR in assessing insulin resistance in acromegaly: a case-control study},
journal = {Endokrynologia Polska},
year = {2025},
doi = {10.5603/ep.105752}
}
EUVIMED